MX2009004237A - Uso de timosina alfa 1 para la preparacion de un medicamento para la prevencion y tratamiento de alergias. - Google Patents

Uso de timosina alfa 1 para la preparacion de un medicamento para la prevencion y tratamiento de alergias.

Info

Publication number
MX2009004237A
MX2009004237A MX2009004237A MX2009004237A MX2009004237A MX 2009004237 A MX2009004237 A MX 2009004237A MX 2009004237 A MX2009004237 A MX 2009004237A MX 2009004237 A MX2009004237 A MX 2009004237A MX 2009004237 A MX2009004237 A MX 2009004237A
Authority
MX
Mexico
Prior art keywords
allergies
medicament
prevention
preparation
treatment
Prior art date
Application number
MX2009004237A
Other languages
English (en)
Inventor
Enrico Garaci
Luigina Romani
Francesco Bistoni
Guido Rasi
Paola Sinibaldi Vallebona
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of MX2009004237A publication Critical patent/MX2009004237A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se relaciona con el uso de timosina alfa 1 para la preparación de un medicamento para la prevención y tratamiento de alergias.
MX2009004237A 2006-10-27 2007-09-27 Uso de timosina alfa 1 para la preparacion de un medicamento para la prevencion y tratamiento de alergias. MX2009004237A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000583A ITRM20060583A1 (it) 2006-10-27 2006-10-27 Uso della timosina alfa 1 per la preparazione di un medicamento per la prevenzione e la cura delle allergie
PCT/IT2007/000676 WO2008050362A2 (en) 2006-10-27 2007-09-27 Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies

Publications (1)

Publication Number Publication Date
MX2009004237A true MX2009004237A (es) 2009-07-07

Family

ID=39322638

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004237A MX2009004237A (es) 2006-10-27 2007-09-27 Uso de timosina alfa 1 para la preparacion de un medicamento para la prevencion y tratamiento de alergias.

Country Status (13)

Country Link
US (1) US20090270594A1 (es)
EP (1) EP2083847A2 (es)
JP (1) JP2010507649A (es)
KR (1) KR20090092267A (es)
CN (1) CN101626778A (es)
AU (1) AU2007310415A1 (es)
BR (1) BRPI0718019A2 (es)
CA (1) CA2666562A1 (es)
EA (1) EA200900603A1 (es)
IL (1) IL198290A0 (es)
IT (1) ITRM20060583A1 (es)
MX (1) MX2009004237A (es)
WO (1) WO2008050362A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
AR020102A1 (es) * 1998-07-30 2002-04-10 Ucb Sa Compuesto para la prevencion y/o tratamiento de la alergia; composicion farmaceutica, composicion cosmetica, composicion en forma de bebida, alimento y/oalimento para animales domesticos que lo comprende y uso de dicho compuesto o dicha composicion farmaceutica para la fabricacion de un alimento
US20060121029A1 (en) * 2002-08-30 2006-06-08 Hiroshi Shiku Method and composition for regulating the activity of regulatory t cells
US8207294B2 (en) * 2003-03-28 2012-06-26 Sciclone Pharmaceuticals, Inc. Treatment of Aspergillus infections with alpha thymosin peptides

Also Published As

Publication number Publication date
EA200900603A1 (ru) 2009-10-30
JP2010507649A (ja) 2010-03-11
EP2083847A2 (en) 2009-08-05
WO2008050362A2 (en) 2008-05-02
IL198290A0 (en) 2011-08-01
KR20090092267A (ko) 2009-08-31
ITRM20060583A1 (it) 2008-04-28
WO2008050362A3 (en) 2008-07-10
BRPI0718019A2 (pt) 2013-11-19
CN101626778A (zh) 2010-01-13
US20090270594A1 (en) 2009-10-29
CA2666562A1 (en) 2008-05-02
AU2007310415A1 (en) 2008-05-02

Similar Documents

Publication Publication Date Title
EP1985302A4 (en) DRUGS FOR TUMOR THERAPY AND ITS USE
ZA200807879B (en) Use of bifidobacterium longum for the prevention and treatment of inflammation
IL207439B (en) Use of an antagonistic antibody against calcitonin gene-related peptide (cgrp) for the preparation of a drug for the prevention and/or treatment of joint pain
HK1129594A1 (en) Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain
ZA200703601B (en) Medicaments for the treatment or prevention of fibriotic diseases
WO2007146426A3 (en) Nanoshells for drug delivery
TWI369210B (en) Use of lgg in the manufacture of a medicament for the prevention or treatment of respiratory allergies
EP1940361A4 (en) PHARMACEUTICAL DOSAGE FORMS HAVING CONTROLLED AND / OR IMMEDIATE RELEASE PROPERTIES
HK1108168A1 (en) Vaccine for prevention and treatment of hiv-infection
IL210589A (en) C2386RV Protein Tuberculosis Kvfb Protein Use for the Treatment or Prevention of TB
EP1991218A4 (en) USE OF CYCLOLIGNANS IN THE TREATMENT OF TYPE 2 DIABETES AND AS CONTRACEPTIVES
EP2101757A4 (en) CONNECTION FOR TREATING OR PREVENTING DISORDERS OF THE PROSTATE AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEREOF OF A COLON DELIVERY SYSTEM
HK1244819A1 (zh) Foxm1肽和包含foxm1肽的藥劑
EP2099441A4 (en) METAL DELIVERY AGENTS AND THERAPEUTIC USES THEREOF
PL1848415T3 (pl) Terapia kombinowana obejmująca octan glatirameru oraz rasagilinę do leczenia stwardnienia rozsianego
EP1814567A4 (en) USE OF MODULATORS OF EPHA2 AND EPHRINA1 FOR TREATING AND PREVENTING INFECTIONS
IL198810A0 (en) Antiviral composition and method of use
UA88655C2 (ru) S-миртазапин для лечения прилива крови
IL197766A0 (en) Use of oritavancin for the prevention and treatment of anthrax
JO2730B1 (en) Medications for the treatment of endometriosis
IL195955A0 (en) Use of thymosin alpha 1 for preparing a medicament for the treatment of stage iv malignant melanoma
EP2005964A4 (en) MEDICAMENT FOR TREATING HYPERPHOSPHATEEMIA AND PREPARATION METHOD THEREOF
WO2008157365A3 (en) Vinylazacycloalkanes for treating neuropathic pain
MX2009004237A (es) Uso de timosina alfa 1 para la preparacion de un medicamento para la prevencion y tratamiento de alergias.
ZA200900257B (en) Use of thymosin Alpha 1 for preparing a medicament for the treatment of stage IV malignant melanoma

Legal Events

Date Code Title Description
FA Abandonment or withdrawal